Establishment of mouse line showing inducible priapism-like phenotypes

Daiki Hashimoto1,2, Kota Fujimoto1,2, Shin Morioka3

  • 1Department of Developmental Genetics Institute of Advanced Medicine, Wakayama Medical University Wakayama Japan.

Abstract

Insights

Researchers identified a new mouse model for priapism, a condition of continuous erection. This discovery highlights phosphatidylinositol (PI) signaling as a potential therapeutic target for priapism and erectile dysfunction (ED).

Area of Science:

  • Reproductive Medicine
  • Molecular Biology
  • Genetics

Background:

  • Erectile dysfunction (ED) and priapism are complex penile disorders requiring further research for effective treatments.
  • Understanding the molecular mechanisms of penile function is crucial for advancing reproductive medicine.

Purpose of the Study:

  • To investigate the molecular processes underlying penile disorders, specifically priapism.
  • To identify novel genetic targets for the treatment and prevention of penile dysfunction.

Main Methods:

  • Generated a novel mouse line with a priapism-like phenotype using N-ethyl-N-nitrosourea mutagenesis and exome sequencing.
  • Identified a mutation in the Pitpna gene associated with the priapism-like phenotype.
  • Conducted histological analyses, intracavernous pressure measurements, and LC-ESI/MS/MS to analyze penile tissue.

Main Results:

  • Established a mouse model exhibiting a priapism-like phenotype due to a Pitpna gene mutation.
  • Demonstrated the role of phospholipids in penile erection for the first time.
  • Quantified significantly lower levels of phosphatidylinositol (PI) in mutant penile samples, suggesting PI's involvement in erection via PITPα.

Conclusions:

  • The identified Pitpna mutant mouse serves as a valuable model for studying priapism.
  • Abnormalities in PI signaling pathways mediated by PITPα are implicated in the development of priapism.
  • This research presents a novel therapeutic target for priapism treatment.

Related Concept Videos